I booked a nice profit on SNGX today, as it spiked up on news of a patent. I’ll be looking to buy back into this company sometime likely within the next couple weeks. I also sold BLRX and will be likely buying that one back sometime in September. It was just a really slow mover and my money is served better in a more active stock.
I added to my position in CKPT, which closed up higher and finished near the high of the day. The chart looks primed for a continuation to my targets soon.
I am also still holding SELB, ADMA, VKTX and VSTM in the portfolio as well.
Reminder: Charts are updated every Sunday evening for the next week!
—– Related —–
This book has helped thousands of other traders learn the basics of biotech, and how to easily spot winning trades.
Whether you are new trader or a 30-year veteran, this book will help you find stocks that are primed to make parabolic moves. These strategies are Kyle’s secret weapons that have help him net over $3 Million in profits…and they are all yours for free.
This is normally $97.00, but it’s yours FREE!
Catalyst Swing Names (1-4 week holds) that I am watching
Checkpoint Therapeutics (CKPT)
Catalyst Dates: Phase 1/2 late breaking data due out September 24th
Buy Zone: $3.55 to $3.95
Profit Zone: $4.50 or higher
Stop Zone: $3.30 or below
Catalyst Dates: Phase 2 topline results due out October 19th
Buy Zone: $.87 to $.92
Profit Zone: $1.00 or higher
Stop Zone: $.85 or below
Catalyst Dates: Phase 3 interim analysis due out in October 2018.
Buy Zone: $1.35 to $1.55
Profit Zone: $1.80 or higher
Stop Zone: $1.15 or below
Mirati Therapeutics (MRTX)
Catalyst Dates: Phase 1 and Phase 2 data due out October 21 and 22.
Buy Zone: $55.00 to $58.00
Profit Zone: $65.00 or higher
Stop Zone: $50.50 or below
Adma Biologics (ADMA)
Catalyst Dates: FDA Approval date of October 25th 2018.
Buy Zone: $5.50 to $5.80
Profit Zone: $6.25 or higher
Stop Zone: $5.30 or below
Catalyst Dates: FDA Approval date of November 3, likely to have an
Advisory Committee meeting announce beforehand.
Buy Zone: $2.60 to $2.90
Profit Zone: $3.40 or higher
Stop Zone: $2.50 or below
Catalyst Dates: FDA approval date of October 5th. Earnings should be August 8th.
Buy Zone: $7.75 to $8.15
Profit Zone: $9.00 or higher
Stop Zone: $7.00 or below
Viking Therapeutics (VKTX)
Catalyst Dates: Phase 2 data due September 30th. Another Phase 2 data set due out likely in late 2018.
Buy Zone: $9.75 to $10.35
Profit Zone: $12.00 or higher
Stop Zone: $9.40 or below
Selecta Biosciences (SELB)
Catalyst Dates: Phase 2 data due out in October
Buy Zone: $12.00 to $13.00
Profit Zone: $16.00 or higher
Stop Zone: $11.50 or below
Catalyst Dates: FDA Approval date of November 2, likely to have an
Advisory Committee meeting announce beforehand
Buy Zone: $1.40 to $1.60
Profit Zone: $2.10 or higher
Stop Zone: $1.30 or below
[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.